The Life Sciences Present A Golden Opportunity For Investors. Learn How! from metlife login for advisers Watch Video

⏲ Duration: 2:43
👁 View: 2.3M times
✓ Published: 18-Apr-2024

Description:
The Life Science industry may present a promising investment opportunity. At the forefront of innovation, the industry is poised to benefit from new technologies like artificial intelligence. The pace of new drug development, for instance, is rapidly accelerating; in 2002 there were 17 new drugs approved, and in 2023, there were nearly 60.<br/><br/>Tema ETFs, an active investment adviser, offers three ETFs focused on life sciences – CANC, HRTS and MNTL.<br/><br/>CANC is Tema's Oncology ETF, investing in the prevention of and cure for cancer.<br/><br/>HRTS is Tema's Obesity and Cardiometabolic ETF, addressing the obesity epidemic.<br/><br/>MNTL is Tema's Neuroscience and Mental Health ETF, investing in the future of cognitive health and science.